NASDAQ · LFSC

F/m Emerald Life Sciences Innovation ETF (LFSC)

$44.55+0.18%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$44.55▲ 51.26% in range
Sep 29, 2025Low $29.44 · High $48.44Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

F/m Emerald Life Sciences Innovation ETF closed at $44.55 on Sep 28, up 0.18%, 8.0% below its 52-week closing high. Volume of 759 shares was 0.26× its 20-day average (below normal).

Split-adjusted performance: -6.2% over one month, +34.6% over six months, +54.8% over one year.

Short interest was 24.7K shares at the Sep 15 settlement, up 24.0% from the prior report (11.2 days to cover).

Market cap$123.7M2.8M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yieldNone
52-week range28.78 – 48.44−8.0% from high
Volume7590.26× 20-day avg
Volatility · 60d24.9%Annualised
Short % of float—11.2 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −1.5%1M −6.2%3M −2.0%6M +34.6%YTD +21.7%1Y +54.8%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short24.7K+24.0% vs prior
Days to cover11.2Settled Sep 15
% of float—
Short vol. 10d51.4%of daily volume

News about F/m Emerald Life Sciences Innovation ETF

All news →

No recent articles focused on F/m Emerald Life Sciences Innovation ETF.

Quick answers

What is LFSC's market cap?
$123.70M, based on the Sep 28 close of $44.55.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology